Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
Author:
Funder
the
Dietmar Hopp Foundation
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/25/1/189/16701404/mdt509.pdf
Reference22 articles.
1. Have drug combinations supplanted stem cell transplantation in myeloma?;Palumbo;Hematology Am Soc Hematol Educ Program,2012
2. Autologous transplantation for multiple myeloma;Harousseau;Ann Oncol,2008
3. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?;Klepin;Bone Marrow Transplant,2006
4. International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation;Cavo;Blood,2011
5. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial;Facon;Lancet,2007
Cited by 68 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Effect of Age on High-Dose Therapy with Autologous Stem Cell Support in Multiple Myeloma: A Single-Center Experience;Journal of Clinical Medicine;2024-07-16
2. Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review;Journal of Geriatric Oncology;2024-04
3. Bendamustine, prednisone and bortezomib (BPV) induction therapy prior autologous stem cell transplantation (ASCT) in 135 newly diagnosed multiple myeloma patients: comparison between patients with normal and impaired renal function;2023-12-11
4. Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis;European Journal of Haematology;2023-01-17
5. Autologous stem cell transplantation for multiple myeloma in the novel agent era: Systematic review of Indian data and implications for resource constrained settings;Journal of Cancer Research and Therapeutics;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3